Updated safety and long‐term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL - Abramson, J; Gordon, L; Palomba, M L (J Clin Oncol, 2018)
et al.